Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bioinformatics analysis revealed hub genes and pathways involved in sorafenib resistance in hepatocellular carcinoma

1 Jan 2019

Abstract excerpt

Hepatocellular carcinoma (HCC) is increasingly known as a serious, worldwide public health concern. Sorafenib resistance is the main challenge faced by many advanced HCC patients. The specific mechanisms of sorafenib resistance remind unclear. In the current study, GEO2R was conducted to identify differentially expressed genes (DEGs) between sorafenib-resistant samples and the control group by using RNA-sequence...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Hepatocellular Carcinoma Treatment and Prognosis
Share to PI3K/AKT/mTOR signaling in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31698564
DOI: 10.3934/mbe.2019315

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bioinformatics analysis revealed hub genes and pathways involved in sorafenib resistance in hepatocellular carcinomaPMID 31698564Read ↗

Comprehensive Network Analysis of the Molecular Mechanisms Associated with Sorafenib Resistance in Hepatocellular CarcinomaSemantic proximity Read ↗

Cytoskeletal gene alterations linked to sorafenib resistance in hepatocellular carcinomaSemantic proximity Read ↗

Transcriptomic Profiling Identifies CSNK1E as a Key Mediator of Sorafenib Resistance in Hepatocellular CarcinomaSemantic proximity Read ↗

Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic HeterogeneitySemantic proximity Read ↗

Identification of most representative hub-genes for diagnosis, prognosis, and therapies of hepatocellular carcinomaSemantic proximity Read ↗

Molecular mechanisms of sorafenib action in liver cancer cellsSemantic proximity Read ↗

Identification of ferroptosis and drug resistance related hub genes to predict the prognosis in Hepatocellular CarcinomaSemantic proximity Read ↗

Identification of a novel Gene Signature and potential mechanisms related to Targeted Drug Resistance in Hepatocellular Carcinoma Based on integrating bioinformatics and machine learningSemantic proximity Read ↗

Low expression of KIF20A suppresses cell proliferation, promotes chemosensitivity and is associated with better prognosis in HCCSemantic proximity Read ↗

TAK1 Is a Novel Target in Hepatocellular Carcinoma and Contributes to Sorafenib Resistance.Semantic proximity Read ↗

Artesunate Sensitizes human hepatocellular carcinoma to sorafenib via exacerbating AFAP1L2-SRC-FUNDC1 axis-dependent mitophagySemantic proximity Read ↗

Identification of hub genes and potential drugs in hepatocellular carcinoma through integrated bioinformatics analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.